These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 544007)

  • 1. Cytocidal effect of rifamycin derivatives on ascites tumor cells: studies with [125I]iododeoxyuridine.
    Hughes AM; Calvin M
    Cancer Lett; 1979 Jan; 6(1):15-9. PubMed ID: 544007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of adenocarcinoma TA3 ascites tumor growth by rifamycin derivatives.
    Hughes AM; Tenforde TS; Calvin M; Bissell MJ; Tischler AN; Bennett EL
    Oncology; 1978; 35(2):76-82. PubMed ID: 652266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic effects of compound 593A (NSC-135758) on mouse leukemias and some transplanted animal tumors.
    Tarnowski GS; Schmid FA; Hutchison DJ; Stock CC
    Cancer Chemother Rep; 1973 Feb; 57(1):21-7. PubMed ID: 4704098
    [No Abstract]   [Full Text] [Related]  

  • 4. Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [1251]-iododeoxyuridine in two human glioblastoma cell lines.
    Xiao WH; Dupertuis YM; Mermillod B; Sun LQ; de Tribolet N; Buchegger F
    Nucl Med Commun; 2000 Oct; 21(10):947-53. PubMed ID: 11130336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytocidal and toxic effect of various cytostatic drugs on three ascites tumors of the mouse.
    Schäfer E; Maurer-Schultze B
    J Cancer Res Clin Oncol; 1987; 113(3):216-22. PubMed ID: 3584212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell loss from several types of solid murine tumour: comparison of 125I-iododeoxyuridine and tritiated thymidine methods.
    Begg AC
    Cell Tissue Kinet; 1977 Sep; 10(5):409-27. PubMed ID: 922795
    [No Abstract]   [Full Text] [Related]  

  • 7. The toxicity of fluorodeoxyuridine when used to increase the uptake of 125I-iododeoxyuridine into tissue culture cells in vitro.
    Holmes JM
    J Comp Pathol; 1983 Oct; 93(4):531-9. PubMed ID: 6227637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of 5-iododeoxyuridine as a measure of tumor growth and tumor inhibition.
    Bonmassar E; Houchens DP; Fioretti MC; Goldin A
    Chemotherapy; 1975; 21(6):321-9. PubMed ID: 1183242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ethidium bromide against transplantable tumors in mice and rats.
    Kramer MJ; Grunberg E
    Chemotherapy; 1973 Oct; 19(4):254-8. PubMed ID: 4801160
    [No Abstract]   [Full Text] [Related]  

  • 10. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity.
    Le Mevel BP; Oldham RK; Wells SA; Herberman RB
    J Natl Cancer Inst; 1973 Nov; 51(5):1551-8. PubMed ID: 4797027
    [No Abstract]   [Full Text] [Related]  

  • 11. Ga-citrate and I-iododeoxyuridine as markers for in vivo evaluation of tumor cell metastasis and death.
    Hofer KG; Swartzendruber DC
    J Natl Cancer Inst; 1973 Apr; 50(4):1039-45. PubMed ID: 4703767
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors.
    Hoshi A; Iigo M; Nakamura A; Yoshida M; Kuretani K
    Gan; 1976 Oct; 67(5):725-31. PubMed ID: 1017587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell kinetic studies of the effect of cytotoxic drugs on survival and proliferation of ascites and solid tumor cells of the mouse.
    Schultze B; Fietkau R; Schäfer E; Bassukas I
    Ann N Y Acad Sci; 1985; 459():278-92. PubMed ID: 3868327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death and metastatic distribution of tumor cells in mice monitored with 125I-iododeoxy-uridine.
    Hofer KG; Prensky W; Hughes WL
    J Natl Cancer Inst; 1969 Oct; 43(4):763-73. PubMed ID: 5344176
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of intratumoral injection of I-125 iododeoxyuridine on Ehrlich ascites carcinoma.
    Hong SS; Ford EH; Alfieri AA; Bravo S
    J Surg Oncol; 1989 Nov; 42(3):187-91. PubMed ID: 2811383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinostatic activity of 4-hydroxy-2-pent-en-1-al against transplantable murine tumour lines.
    Conroy PJ; Nodes JT; Slater F; White GW
    Eur J Cancer (1965); 1975 Apr; 11(4):231-40. PubMed ID: 124656
    [No Abstract]   [Full Text] [Related]  

  • 17. The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone.
    French FA; Blanz EJ
    Cancer Res; 1965 Oct; 25(9):1454-8. PubMed ID: 5862990
    [No Abstract]   [Full Text] [Related]  

  • 18. Double labeling with [3H]thymidine and [125I]iododeoxyuridine as a method for determining the fate of injected DNA and cells in vivo.
    Myers DK; Feinendegen LE
    J Cell Biol; 1975 Nov; 67(2PT.1):484-8. PubMed ID: 1194358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model.
    Bloomer WD; Adelstein SJ
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):513-25. PubMed ID: 639561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytostatic effect of 1-methyl-2-(p-(bis-(beta-chlorethyl)-amino)-phenyliminomethyl)-quinolinium chloride (IMET 3106) on the growth of transplantable neoplasms].
    Jungstand W; Gutsche W; Wohlrabe K
    Arch Geschwulstforsch; 1972; 40(1):35-9. PubMed ID: 4510766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.